Stockchase Opinions

Stockchase Insights Estee Lauder EL-N PARTIAL BUY May 21, 2025

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

There is still lots of risk here but we think the potential is also looking good from current levels. The company is still quite levered, but it generates good cash flow. EPS will fall this year but better things are expected in 2026. With its slowdown, the company has some serious cost-cutting efforts ongoing, and if these work there is good leverage to earnings. We would not want a lot, and it is for recovery-style patient investors only, but we think it will ultimately recover well enough.
Unlock Premium - Try 5i Free

$63.660

Stock price when the opinion was issued

Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

Is down 16% in May. She expected things to imnrpove when she bought it; that hasn't happened yet, but weakness in the Chinese consumer may be bottoming while more marketing should help.

PARTIAL SELL

He sold some of his holdings. A disaster. A loser he held onto when sales in China failed to triumph.

SELL

It reported a beat this morning, but they always set a really low bar in earnings, and the long-time CEO announced his retirement. The CEO guided it to great heights, but recent disastrous declines in earnings. The pandemic hurt their Chinese sales and that has never recovered; also, airport sales haven't recovered. Since the start of 2022, Estee Lauder has sank 75% while ELF has soared 382%. Lauder maintained high prices to protect their margins, but that may be working anymore. 

TOP PICK

Fundamental driver of business very strong - vanity products. Long history of well established brands. China growth has slowed, but overall is optimistic on company. Not founder run, but founder still owns large chunk of business. Is ~1% position in portfolio. Will keep buying on share price weakness. 

DON'T BUY

If the Chinese consumer continues to recover, EL will do well. But even with the stimulus announced in China this week, China won't come roaring back.

TRADE

He'd own it for the next couple of months, but questions the next couple of years. Clinique is strong, but has lost some of its brand "heat". Weaker topline. Revenue coming down at the same time as costs are inflating. Tactically bullish if you believe the spurt in China is real, but tends to get more competitive over the long term, and that will come home to roost for EL over a 5-year horizon.

See his Top Picks for a more durable idea.

DON'T BUY

Enjoys their products and notes they are sector leaders. They score 9/10 overall. The current pullback makes her cautious though. It could be a while before this turns around. They did beat their last quarter.

WEAK BUY

Strong brand. Liked the growth in Asia. Moved online very well during Covid. China slowing has hurt a lot of luxury brands. New CEO. Cut outlook for next year. Opportunity for stock to go up from here, but you need Asia to come back. Needs to exit lagging brands.

DON'T BUY

Estee overplayed its hand in terms of how much it costs to shop, not realizing that the consumer around the world has changed and wants more value than they used to. The stock has performed so poorly for so long.